Andrew J. Schwab - 24 Feb 2025 Form 4 Insider Report for Skye Bioscience, Inc. (SKYE)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SKYE	Stock Option (Right to Buy)	Award	$0	+35,000		$0.000000	35,000	24 Feb 2025	Common Stock	35,000	$2.89	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The stock option vests in equal monthly installments over the one year period beginning February 21, 2025.